Clinical Psychopharmacology and Neuroscience indexed in CAS, DOI/Crossref, EMBASE, Korea Citation Index (KCI), KoreaMed, Korea Medical Citation Index (KoMCI), PubMed, PubMed Central (PMC), SCOPUS, SCI-expanded (SCIE), and Google Scholar:eISSN 2093-4327   pISSN 1738-1088

Download original image
Fig. 2. Protein expression of CNGB1 in MIA model. (A) CNGB1 expression was detected by Western blot analysis with an anti-b-tubulin antibody (Tubb) as an internal control. Animal models induced by poly I:C exhibited decreased CNGB1 expression in the prefrontal cortex. (B) Quantitative analysis of Western blot analysis data for CNGB1 expression showed a significant difference in CNGB1 levels between CON and MIA groups (*p < 0.05). CON, control group; CON + CLZ, Clozapine-treated CON group; MIA, offspring of mice injected with poly I:C group; MIA + CLZ, clozapine-treated MIA group.
Clin Psychopharmacol Neurosci 2021;19:618~627 https://doi.org/10.9758/cpn.2021.19.4.618
© Clin Psychopharmacol Neurosci